Doctors criticise Eli Lilly's direct-to-consumer platform for GLP-1 drugs
1 outlet · 1L · 0C · 0R
First reported
1 / 1
We're still gathering coverage of this story.
A neutral account and the side-by-side comparison are written once at least 2 outlets have reported it. Here is the coverage so far.
Left1 article
Centre0 articles
No coverage yet.
Right0 articles
No coverage yet.
- 30 Sep 19:54 First ABC News (Australia)LC 'US-style medicine model' as big pharma dispensing of GLP-1s condemned
Times are when each article was published, or when we first saw it if the outlet gave no time.